NCI maintains paylines for early-stage investigators, cuts funding for other R01s and noncompeting grants in FY24

As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention

As biomedical research at NIH faces an existential threat from the Trump administration, an entrepreneur is winning over allies for what he describes as a “simple idea” that could introduce a massive new infusion of money for innovation in medicine.

June 20, 2025

Vol.51 No.24

By Jacquelyn Cobb

Conversation with The Cancer Letter

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one...

June 20, 2025

Vol.51 No.24

By Otis W. Brawley and Paul Goldberg

Cancer Policy

“Forward funding” NIH budget plan would make competing for grants much harder

In the fiscal year 2026 budget request, the Trump administration proposes “forward funding,” or multiyear funding, of awards.

June 20, 2025

Vol.51 No.24

By Claire Marie Porter

Podcast

The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it”

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers.

Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing”

In a 96-minute hearing in front of the Senate Appropriations Committee on the Trump administration’s budget, senators slammed NIH Director Jay Bhattacharya for not taking responsibility for the funding cuts to research and upheaval at NIH.

June 13, 2025

Vol.51 No.23

By Claire Marie Porter

Regulatory News

In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times
“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.”

In the first meeting of the National Cancer Advisory Board since the inauguration of President Donald Trump, NCI Principal Deputy Director Douglas R. Lowy addressed many of the burning questions the oncology field has for the institute. On indirect costs: NCI will continue to use previously negotiated and approved indirect cost rates, with the exception...

June 13, 2025

Vol.51 No.23

By Jacquelyn Cobb

NCI maintains paylines for early-stage investigators, cuts funding for other R01s and noncompeting grants in FY24

YOU MAY BE INTERESTED IN

As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

“Forward funding” NIH budget plan would make competing for grants much harder

The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it”

Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing”

In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times
“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.”

Renew today!

Subscriber content

Never miss an issue!

Login

NCI maintains paylines for early-stage investigators, cuts funding for other R01s and noncompeting grants in FY24

YOU MAY BE INTERESTED IN

As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

“Forward funding” NIH budget plan would make competing for grants much harder

The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woesDirectors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it”

Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheavalSusan Collins: Trump’s 40% cut is “so disturbing”

In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.”

Never miss an issue!

Login

The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it”

Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing”

In first NCAB meeting since Trump’s inauguration, Lowy reflects on funding choices in lean times
“In the NCI director’s office, we have a photograph of a stone bridge, and it asks the question, which stone holds up the bridge? And the answer is all of them.”